Nanobiotix Shares Halted on Euronext Paris Ahead of Global Offering Pricing
summarizeSummary
Trading of Nanobiotix's ordinary shares on Euronext Paris has been temporarily halted at the company's request. This halt is in preparation for the pricing and allocation confirmation of a previously announced Global Offering, which includes a public offering of ADSs in the US and an offering of shares/warrants in Europe. This event is significant as it signals the imminent announcement of terms for a potentially dilutive capital raise. Trading is expected to resume later today, May 21, 2026, at approximately 3:30 p.m. Paris time, when the pricing details are anticipated.
At the time of this announcement, NBTX was trading at $40.14 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.2B. The 52-week trading range was $3.64 to $57.14. This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.